References
- 1. Fowker FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2010 and 2010: a systemic review and analysis. Lancet. 2013;382:1329-1340.10.1016/S0140-6736(13)61249-0
- 2. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509-1526.10.1161/CIRCRESAHA.116.30384925908725
- 3. Jacoby DS, Mohler ER. Peripheral arterial disease. Risk factor identification and modification. In: Abela GS, editor. Peripheral Vascular Disease. Basic Diagnostic and Therapeutic Approaches. Lippincott Williams and Wilkins; 2004. p. 190-9.
- 4. Zipes D, Libby P. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 11th Edition; 2018.
- 5. Herman G, Gornik HL, Barrett C, et al.2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e726-e779.10.1161/CIR.000000000000050228320816
- 6. Tseng A, Louka B, Shamoun F, Esser H, Morcos R, McBane, Misra RS. The Evolving Treatment of Peripheral Arterial Disease through Guideline - Directed Recommandations, J Clin Med. 2018 Jan; 2018;7(1):9.
- 7. Costel M. Bolile arterelor periferice. In Ginghină C et al. Mic tratat de cardiologie. București. Editura Academiei Române; 2017; p. 967-77.
- 8. Aboyans V, Ricco JB, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. European Heart Journal. 2018;39(9):763-816.10.1093/eurheartj/ehx09528886620
- 9. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Lie- benthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000;102:3060-3067.10.1161/01.CIR.102.25.3060
- 10. Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, Yusuf S. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J. 2004;25:17-24.10.1016/j.ehj.2003.10.03314683738
- 11. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA.2012;308:1660-1667. doi:10.1001/jama.2012.13415.10.1001/jama.2012.13415373310623093164